CIC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.112100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.949900E-02
Normal-vs-Stage2
6.328000E-02
Normal-vs-Stage3
5.990000E-02
Normal-vs-Stage4
1.498630E-01
Stage1-vs-Stage2
9.383800E-01
Stage1-vs-Stage3
2.671800E-01
Stage1-vs-Stage4
6.400400E-01
Stage2-vs-Stage3
2.162600E-01
Stage2-vs-Stage4
6.263200E-01
Stage3-vs-Stage4
1.798640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.739600E-02
Normal-vs-AfricanAmerican
1.182620E-01
Normal-vs-Asian
4.524000E-01
Caucasian-vs-AfricanAmerican
7.058800E-01
Caucasian-vs-Asian
4.757000E-01
AfricanAmerican-vs-Asian
7.665800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.801600E-02
Normal-vs-Female
6.287800E-02
Male-vs-Female
6.015200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.835600E-01
Normal-vs-Age(41-60Yrs)
1.312580E-01
Normal-vs-Age(61-80Yrs)
5.159600E-02
Normal-vs-Age(81-100Yrs)
1.587540E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.036000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.819200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.375200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.527800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.918300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.383000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.744000E-02
Normal-vs-Daily Drinker
5.318200E-02
Normal-vs-Weekly Drinker
1.899400E-01
Normal-vs-Occasional Drinker
4.576600E-01
Normal-vs-Social Drinker
4.997600E-02
Non Drinker-vs-Daily Drinker
6.853200E-01
Non Drinker-vs-Weekly Drinker
2.290000E-01
Non Drinker-vs-Occasional Drinker
1.173970E-01
Non Drinker-vs-Social Drinker
4.838000E-01
Daily Drinker-vs-Weekly Drinker
3.478200E-01
Daily Drinker-vs-Occasional Drinker
2.108600E-01
Daily Drinker-vs-Social Drinker
7.108200E-01
Weekly Drinker-vs-Occasional Drinker
7.039800E-01
Weekly Drinker-vs-Social Drinker
5.463600E-01
Occasional Drinker-vs-Social Drinker
3.551800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.185200E-01
Normal-vs-Grade 2
6.800000E-01
Normal-vs-Grade 3
6.556800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.128200E-01
Grade 1-vs-Grade 3
3.308200E-01
Grade 1-vs-Grade 4
4.185200E-01
Grade 2-vs-Grade 3
5.618800E-01
Grade 2-vs-Grade 4
6.800000E-01
Grade 3-vs-Grade 4
6.556800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.505600E-02
Normal-vs-NonDiabetic
1.074600E-01
Diabetic-vs-NonDiabetic
1.796640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.216300E-02
Normal-vs-NoPancreatitis
7.830400E-02
Pancreatitis-vs-NoPancreatitis
5.361800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.347600E-02
Normal-vs-N1
4.937600E-02
N0-vs-N1
9.071400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.860100E-02
Normal-vs-TP53-NonMutant
1.096850E-01
TP53-Mutant-vs-TP53-NonMutant
6.634200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
